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Abstract: Celiac disease is a chronic, immune-mediated disorder, characterized by small 
intestinal inflammation and villous atrophy after the ingestion of gluten by genetically 
susceptible individuals. Several extraintestinal manifestations have been associated to 
celiac disease. Eosinophilic esophagitis is a primary disorder of the esophagus 
characterized by upper gastrointestinal symptoms, absence of gastroesophageal reflux 
disease and more than 15 eosinophils per high-power field in biopsy specimens. Both 
celiac disease and eosinophilic esophagitis are caused by aberrant, but distinct, immune 
responses to ingested antigens and can be responsive to restricted food intake. The aim of 
this review is to assess whether there is an association between these two pathologies. In 
the majority of the studies examined, including the studies in pediatric population, the 
prevalence of eosinophilic esophagitis in subjects with celiac disease was about 10-times 
that of the general population. We suggest searching for eosinophilic esophagitis in all 
children undergoing endoscopy for suspicious celiac disease. 
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1. Introduction 
Celiac disease is a chronic, immune-mediated disorder, characterized by malabsorption of nutrients 
after the ingestion of wheat gluten or related proteins from rye and barley by genetically susceptible 
individuals expressing the human leukocyte antigen (HLA) class II molecules DQ2 or DQ8 [1] 
resulting in villus atrophy of the small intestinal mucosa. Prompt clinical and histologic improvement is 
observed following strict adherence to a gluten-free diet, and clinical and histologic relapse occurs when 
gluten is reintroduced [2]. Several extraintestinal manifestations, including anemia, osteopenia, 
neurologic symptoms, menstrual abnormalities, infertility, recurrent spontaneous abortions, growth 
retardation, dermatitis herpetiformis, aphthous stomatitis, dental defects, have been associated with 
celiac disease [3]. 
Eosinophilic esophagitis was first described in 1978 [4]; however, it became recognized as a 
distinct clinical entity in 1995 [5]. It is a chronic inflammatory primary disorder of the esophagus, 
presenting with dysphagia and symptoms mimicking those of gastroesophageal reflux disease, 
including vomiting, regurgitation, nausea and epigastric pain. This disorder is characterized by 
esophageal mucosal biopsy containing more than 15 eosinophils per high-power field (Figure 1) and 
absence of gastroesophageal reflux disease, as shown by normal pH monitoring or lack of response to 
high-dose proton pump inhibitory therapy [6]. 
Figure 1. Classic histological findings of eosinophilic esophagitis: hypereosinophilia, usually 
with >15–20 eosinophils per high-powered field. Eosinophils in the squamous mucosa are 
visible (arrows). (Courtesy of Dr. Ezio David, MD, Molinette Hospital, Turin, Italy.) 
 
There are some classic endoscopic features including adherent whitish plaques, esophageal 
concentric rings, linear furrowing, but the esophagus can appear only slightly altered in some  
patients [7]. The squamous epithelium of the esophagus is normally devoid of eosinophils, but various 
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disorders cause eosinophils to infiltrate the esophageal epithelium: parasitic infections, autoimmune 
disease, vasculitis, medications, gastroesophageal reflux disease [8]. When first described, eosinophilic 
esophagitis was believed to be a predominantly pediatric condition; however, it is now commonly 
diagnosed in adults as well as in children [9]. The clinical presentation of eosinophilic esophagitis may 
vary depending on age: younger children, generally present with non-specific symptoms of 
gastroesophageal reflux disease, abdominal pain or failure to thrive [10]; older children often present 
with dysphagia and esophageal food impaction [11]; however, asymptomatic low-grade counts of 
epithelial eosinophils (less than 15 eosinophils per high-power field) may be more common than has 
been estimated, but are of uncertain clinical significance [12]. A subset of patients with eosinophilic 
esophagitis responds to acid suppressive therapy, indicating some overlap between eosinophilic 
esophagitis and gastroesophageal reflux disease [6]; this is now considered as a separate entity labelled 
“proton pump inhibitors (PPI) responsive oesophageal eosinophilia” [13] In children, eosinophilic 
esophagitis has been shown to be associated with IgE- and non-IgE-mediated food allergy, and the 
majority of cases respond to elemental diets or specific food protein elimination [6]. By contrast, in 
adults the response to dietary interventions is less predictable, and the treatment more commonly relies 
on swallowed corticosteroid aerosols [6]. The poor response rate to dietary interventions in adults may 
be due to a lower prevalence of food allergy, and sensitization to inhalant allergens may play a more 
significant etiological role [6]. The data about the incidence of eosinophilic esophagitis range from  
0.5 cases per 10,000 [14] to 1 in 10,000 in Ohio, USA [15] and the prevalence range from 0.89/10,000 
in Western Australia [16] to four cases per 10,000 in Ohio, USA [15] and 5.5 cases per 10,000 in 
Olmsted County, Minnesota, USA [17]. The incidence seems to be increasing in both adults and 
children, though it is as yet unclear whether this is solely attributable to increasing awareness and 
detection of the disease or whether it represents a genuine phenomenon [18]. There is a male 
predominance, with 76% of adult and 66% of pediatric cases being diagnosed in males [6]. Since both 
celiac disease and eosinophilic esophagitis are caused by aberrant, but distinct, immune responses to 
ingested antigens and can be responsive to food elimination diets, the objective of our study was to 
verify if there is an association between these two conditions. 
2. Experimental Section 
Articles regarding the association of these two diseases were identified through MEDLINE search 
using the terms “celiac disease or celiac sprue or gluten AND eosinophilic esophagitis”. The search 
was also performed using reference lists from published articles. The titles of these publications and 
their abstracts were scanned in order to eliminate duplicates and irrelevant articles. The final date of 
the MEDLINE search was June 19, 2013. 
3. Results 
The search identified 30 publications (from November 2001 to May 2013) on this subject. We read 
the abstracts of all articles and selected the 13 original articles in which associations between the two 
diseases were addressed; three were excluded because there were no data about the prevalence of the 
diseases. Celiac disease and eosinophilic esophagitis have been described in the same patient for the 
first time in a case report of 2007 [19] in a 7-year old black male with reactive airway disease, eczema 
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and type 1 diabetes mellitus referred to the gastroenterology clinic for positive celiac serologic 
findings in recurrent abdominal pain. The eosinophilic esophagitis responded to an elimination diet 
with normalization of esophageal histology and subsequently recurred with reintroduction of cow’s 
milk protein (while celiac disease’s histology remained in remission with gluten-free diet). A second 
report of three associated cases was described in the same year [20] with a reported prevalence of 
eosinophilic esophagitis in patients with celiac disease of 9%, nine times higher than that expected in 
the general population (1:100) [21]. In one patient eosinophilic esophagitis disappeared after  
gluten-free diet; in the other two cases, the gluten-free diet did not have any effect on the eosinophilic 
infiltrate, but both subjects were not compliant to the gluten-free diet. Another study [22] reported a 
35% of prevalence of celiac disease in 17 patients affected by eosinophilic esophagitis investigated for 
upper gastrointestinal symptoms, with a significant clinical and histological remission on gluten-free 
diet compared to the group of patients with eosinophilic esophagitis without celiac disease. In an 
Australian study regarding seven children with eosinophilic esophagitis and celiac disease [23], no 
patients with food allergy were reported; the prevalence of eosinophilic esophagitis in the cohort of 
patients with celiac disease was 3.1%; two of seven patients who underwent repeated endoscopic 
examinations showed improved duodenal histology but persistent eosinophilic esophagitis on  
gluten-free diet. In another Australian study published in 2010 [24], the prevalence of esophageal 
eosinophilia in children with celiac disease who had concurrent esophageal biopsies was 8.2% (10 of 
121), 60% males, 30% had normal-appearing esophageal mucosa at endoscopy; children who had 
undergone repeated endoscopic examinations showed recovery of duodenal mucosa but no resolution 
of esophageal eosinophilia on a gluten-free diet alone. The association of celiac and eosinophilic 
esophagitis may not be a true association but a matter of biased enrollment in the above studies: 
regarding HLA DQ2 and/or DQ8, a study [25] showed that these alleles were not present in 
eosinophilic esophagitis at a greater rate than in healthy controls. But a recent study [26] demonstrated, 
a clear association between celiac disease and eosinophilic esophagitis in both pediatric and adult 
populations: the standardized incidence ratio of eosinophilic esophagitis in patients with celiac disease 
was 16.0 (95% CI, 8.7–25.5). A general population-based study on adults [27] did not find any 
association between eosinophilic esophagitis and celiac disease, whereas the latest one [28] showed a 
prevalence of 1.2% of eosinophilic esophagitis in children with celiac disease (Table 1). 
Table 1. Published study about prevalence of eosinophilic esophagitis (EoE) in patients 
affected by celiac disease (CD). 
Study Country 
Prevalence of EoE 
in CD population 
% of Pediatric 
patients 
% of Male in 
EoE patients 
Population 
A [22] Australia 3.1% (7 of 221) 100 43 Tertiary center 
B [23] Australia 8.2% (10 of 121) 100 60 Tertiary center 
C [25] USA 0.97% (14 of 1439) 20.6 57 Tertiary center 
D [27] Canada 1.2% (3 of 245) 100 100 General population 
4. Discussion 
Both celiac disease and eosinophilic esophagitis are distinct clinical entities except for a few minor 
similarities. Celiac disease is a Th1 mediated disorder which aligns with autoimmunity, triggered by 
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the ingestion of food containing gluten and affects females:males at a ratio of 2:1 [29]. By contrast, 
eosinophilic esophagitis has been shown to be a Th2-mediated disorder, which is triggered by exposure 
to dietary allergens causing infiltration of the esophageal mucosa by T lymphocytes, mast cells and 
eosinophils and predominates in males, with a 3:1 ratio to females. There is also an overexpression of 
eotaxin-3 and interleukin-5 [6] in the latter. Affliction of 8% of first-degree relatives of patients with 
celiac disease is similar to that reported in 10% of first-degree relatives of patients with eosinophilic 
esophagitis [30]. The genetic basis for celiac disease (i.e., HLA DQ2) is well established and differs 
from that of eosinophilic esophagitis [25] whose etiology is far from clear, but in nearly 50% of the 
cases, it is associated with an allergy to food or to aeroallergens [15]. In children, IgE-dependent 
mechanism for eosinophilic esophagitis is supported; for instance, it was shown that affected patients 
have IgE sensitization to a wide variety of foods, although not all patients had evidence of  
food-specific IgE [31]. In one study, a higher level of IgE sensitization to food allergens was observed 
in patients with eosinophilic esophagitis alone compared to patients with both pathologies, and this led 
the authors to hypothesize that patients with both pathologies have elevated esophageal eosinophils for 
reasons different from allergy, with a significant clinical and histological remission on gluten-free  
diet [22]. Increased intestinal mucosal permeability secondary to celiac disease has been suggested as a 
contributing factor in the development of atopy [32,33]. Damaged intestinal barrier may expose the 
local intestinal immune system to macromolecules and lead to transport of these undigested proteins to 
other body sites, hence facilitating development of hypersensitivity reactions in a predisposed 
individual in and away from the gastrointestinal tract [23]. By contrast, in adults, the response to 
dietary interventions is less predictable, and treatment more commonly relies on swallowed 
corticosteroid aerosols [6]. The clinical significance of eosinophilic esophagitis as an incidental finding 
is uncertain; if the main treatment goal is suppression of clinical symptoms, asymptomatic eosinophilic 
esophagitis may not require any therapy, but as the natural history of eosinophilic esophagitis in 
largely unknown, it is unclear what proportion is at risk of developing esophageal strictures and 
dysphagia in the long term [34]. 
5. Conclusions 
In summary, although there are fundamental differences in the pathophysiological mechanisms 
involved in eosinophilic esophagitis and celiac disease, these conditions may coexist and the 
prevalence is higher than anticipated. Our review highlights the importance of obtaining routine 
esophageal biopsies in children undergoing endoscopy for diagnosis of celiac disease irrespective of 
whether the esophagus appears normal or abnormal at endoscopy; however, asymptomatic low-grade 
counts of epithelial eosinophils are of uncertain clinical significance. 
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